Influence of Combined Methionine Synthase (MTR 2756A>G) and Methylenetetrahydrofolate Reductase (MTHFR 677C>T) Polymorphisms to Plasma Homocysteine Levels in Korean Patients with Ischemic Stroke
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Purpose: Methionine synthase (MTR) and 5,10-methylenetetrahydrofolate reductase (MTHFR) are the main regulatory enzymes for homocysteine metabolism. The present case- control study was conducted to determine whether there is an association between the MTR 2756A>G or MTHFR 677C >T polymorphism and plasma homocysteine concentration in Korean subjects with ischemic stroke. Materials and Methods: DNA samples of 237 patients who had an ischemic stroke and 223 age and sex-matched controls were studied. MTR 2756A>G and MTHFR 677C>T genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results: Frequencies of mutant alleles for MTR and MTHFR polymorphisms were not significantly different between the controls and cases. The patient group, however, had significantly higher homocysteine concentrations of the MTR 2756AA and MTHFR 677TT genotypes than the control group (p=0.04 for MTR, p=0.01 for MTHFR). The combined MTR 2756AA and MTHFR 677TT genotype (p= 0.04) and the homocysteine concentrations of the patient group were also higher than those of the controls. In addition, the genotype distribution was significant in the MTHFR 677TT genotype (p=0.008) and combined MTR 2756AA and MTHFR 677TT genotype (p=0.03), which divided the groups into the top 20% and bottom 20% based on their homocysteine levels. Conclusion: The results of the present study demonstrate that the MTR 2756A>G and MTHFR 677C>T polymorphisms interact with elevated total homocysteine (tHcy) levels, leading to an increased risk of ischemic stroke.
참고문헌 (38)
- "Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations", 17, pp.298~309 (1999)
- "Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c → t methylenetetrahydrofolate reductase and 2756a → g methionine synthase genotypes", 70, pp.27~44 (2000)
- "5,10-Methylenetetrahydrofolate reductase 677C→T and 1298A→C mutations are genetic determinants of elevated homocysteine", 96, pp.297~303 (2003)
- "The effect of 677C→T and 1298A→C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects", 83, pp.593~596 (2000)
- "A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations", 129, pp.1656~1661 (1999)
- "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase", 10, pp.111~113 (1995)
- "Elevated plasma homocysteine in acute stroke was not associated with severity and outcome: stronger association with small artery disease", 26, pp.310~318 (2005)
- "Changes in plasma homocyst(e)ine in the acute phase after stroke", 33, pp.473~478 (2002)
- "Hyperhomocysteinemia as an independent risk factor for silent brain infarction", 61, pp.1595~1599 (2003)
- "Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small- artery occlusions", 111, pp.39~44 (2003)
- "The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk", 133, pp.1281~1285 (2003)
- "A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk", 79, pp.522~528 (2001)
- "Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians", 94, pp.2410~2416 (1996)
- "Plasma homocysteine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area", 30, pp.969~973 (1999)
- "Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with genetic susceptibility to gastric cancer: a meta-analysis", 51, pp.618~624 (2006)
- "Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population", 28, pp.154~159 (2006)
- "Homozygous V", V (677C to T) and D, pp.2001, 33[DOI]
- "Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia", 26, pp.2879~2881 (2006)
- "Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population", 25, pp.2249~2252 (2005)
- "Methylenetetrahydrofolate reductase gene polymorphisms in patients with Down syndrome", 26, pp.431~436 (2004)
- "Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion", 117, pp.653~658 (2006)
- "Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis", 36, pp.1581~1587 (2005)
- "Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate", cobalamin disorders, 1996, pp.4, 1867~1874
- "The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study", 110, pp.87~91 (2003)
- "Influence of a methionine synthase (D919C) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction", 154, pp.667~672 (2001)
- "Polymorphism of the methionine synthase gene: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population", 19, pp.298~302 (1999)
- "Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases", 143, pp.163~170 (1999)
- "A polymorphism of the methionine synthase gene: Association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk", 8, pp.825~829 (1999)
- "Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects", 78, pp.216~221 (2003)
- "Interaction between common folate polymorphism and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event", 79, pp.201~213 (2003)
- "Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population", 47, pp.319~324 (2002)
- "Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population", 146, pp.133~140 (1999)
- "Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases", 104, pp.187~195 (2001)
- "Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991", pp.5444~
- "Three different methods for the determination of total homocysteine in plasma", 32, pp.218~220 (1995)
- "B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)", 13, pp.239~248 (2002)
- "Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma", 97, pp.3205~3209 (2001)
- "Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk", 13, pp.157~162 (2004)
